Celldex Therapeutics
CLDX
#4623
Rank
A$3.23 B
Marketcap
A$41.25
Share price
-1.66%
Change (1 day)
7.42%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): A-$6.41

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is A-$6.53. In 2025 the company made an earnings per share (EPS) of A-$5.84 a decrease over its 2024 EPS that were of A-$3.68.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$6.419.92%
2025A-$5.8458.78%
2024A-$3.68
2022A-$3.5945.73%
2021A-$2.46-23.36%
2020A-$3.21-41.05%
2019A-$5.45-76.95%
2018A-$23.63
2016A-$28.35-3.82%
2015A-$29.48-0.76%
2014A-$29.70
2012A-$22.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.07-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.32-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
A-$6.59 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
A-$6.02-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$3.03-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$7.56 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA